Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Death by Light

Abstract:
Nanoparticles as agents for the photodynamic killing of antibiotic-resistant bacteria

Death by Light

Germany | Posted on October 7th, 2009

The increasing antibiotic resistance of bacteria is a serious problem of our time. Hospital germs in particular have developed strains against which practically every current antibiotic is ineffective. In the battle against resistant microbes, a team at the University of Münster (Germany) is now pursuing a new approach involving photodynamic therapy, which is a technique that is already being used in the treatment of certain forms of cancer and macular degeneration. Upon irradiation with light, an agent produces oxygen in a special activated form that is highly toxic to cells. As the researchers led by Cristian A. Strassert and Luisa De Cola report in the journal Angewandte Chemie, they would like to use specially developed nanomaterials that bind specifically to bacterial cells to mark them and kill them under irradiation.

The researchers use nanoparticles made of a special porous material (zeolite L). The particles are modified so they carry a coating of amino groups. These bind preferentially to the surfaces of bacterial cells by means of electrostatic attraction and hydrogen bonds. The researchers put a green fluorescent dye into the channels of the mineral, making the bacteria visible under a fluorescence microscope. The actual "weapons" are photosensitizers anchored on the surface of the nanoparticles. When these molecules are irradiated with light of the right wavelength, they absorb the light energy and transfer it to oxygen molecules found in the surroundings, for example in infected tissue. The oxygen is excited and enters into what is known as the singlet state, in which it is highly reactive and attacks biomolecules - but only in the immediate area in which the singlet oxygen was generated. In this case, the location is right on the bacterial cell where the mineral particle is bound.

The scientists tested their new light-activated killer particles on antibiotic-resistant cultures of E. coli bacteria. After about two hours of irradiation, the bacteria were almost completely killed off. The team achieved comparable results with a strain of resistant gonococci. Furthermore, the researchers from Münster are also considering this material for the treatment of skin cancer. In this case, the tumor cells could be destroyed upon targeted irradiation with red light.

Author: Luisa De Cola, Westfälische Wilhelms-Universität Münster (Germany),
www.uni-muenster.de/Physik.PI/DeCola/ldc.html

Title: Photoactive Hybrid Nanomaterial for Targeting, Labeling, and Killing Antibiotic-Resistant Bacteria

Angewandte Chemie International Edition 2029, 68, No. 42, 7928-7931, doi: 10.1002/anie.200902837

####

For more information, please click here

Contacts:
Editorial office:
or Amy Molnar (US): or Jennifer Beal (UK): or Alina Boey (Asia):

Copyright © Angewandte Chemie

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Possible Futures

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Nanobiotechnology

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project